Innovative Trial Design & Master Protocols: Lisa Lavange | Pod of Asclepius
About this episode
Lisa LaVange (Gillings School of Global Public Health at the University of North Carolina at Chapel Hill) was the 2018 American Statistical Association (ASA) president and the director of the Office of Biostatistics in the Center for Drug Evaluation and Research (CDER) at the FDA.
She give a high-level overview of issues surrounding Innovative Trial Design and Master Protocols. A great listen for anyone wanting to be introduced to the subject or (for those already familiar) interested in its growing breadth of applications.
#datascience #statistics #biopharm #pharma #FDA
Get every episode summarized
Each time Data & Science with Glen Wright Colopy publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Data & Science with Glen Wright Colopy
Keith O’Rourke | The Logic of Statistics
Data & Science with Glen Wright Colopy
Jack Fitzsimons | Evil Models: Hiding Malware in Neural Networks
Data & Science with Glen Wright Colopy
Scott Cunningham | Causal Inference (The Mixtape)
Data & Science with Glen Wright Colopy
Eric Daza | Important Ideas in Causal Inference
Data & Science with Glen Wright Colopy